Clinical Trials in Khoudh, Oman
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 4
Asciminib Roll-over Study
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals347 enrolled85 locationsNCT04877522
Recruiting
Phase 4
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Sickle Cell Disease
Novartis Pharmaceuticals130 enrolled31 locationsNCT04657822